A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
Clinical trial NCT01352845 · COMPLETED
Trial details
- NCT number
- NCT01352845
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2015-02-01
- Enrollment
- 3301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.